Chad H. Martin - Jul 27, 2021 Form 4 Insider Report for MeridianLink, Inc. (MLNK)

Role
Chief Financial Officer
Signature
/s/ Kayla Dailey, as Attorney-in-Fact
Stock symbol
MLNK
Transactions as of
Jul 27, 2021
Transactions value $
$0
Form type
4
Date filed
7/29/2021, 07:52 PM
Next filing
Aug 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLNK Common Stock, par value $0.001 Award $0 +51.5K +9.66% $0.00 585K Jul 27, 2021 Direct F1
holding MLNK Common Stock, par value $0.001 99.9K Jul 27, 2021 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLNK Stock Option (option to buy) Award $0 +129K $0.00 129K Jul 27, 2021 Common Stock, par value $0.001 129K $26.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were granted pursuant to a restricted stock unit award ("RSU"). 25% of the shares subject to the RSU award shall vest on July 27, 2022, and the remaining 75% of the shares subject to the RSU award shall vest in 12 equal quarterly installments thereafter on the first day of the applicable month beginning at the start of the first calendar quarter following July 27, 2022, subject to the reporting person's continued service relationship with the Issuer through each such vesting date.
F2 The shares are held directly by the Martin Family Trust dated March 9, 2010. The reporting person and his spouse are the co-trustees of the Martin Family Trust dated March 9, 2010 and share sole voting and dispositive power with respect to all securities held by such entity, and the reporting person may be deemed to be the beneficial owner of the securities held by the Martin Family Trust dated March 9, 2010.
F3 25% of the shares underlying the option shall vest and become exercisable on July 27, 2022, and the remaining 75% of the shares underlying the option shall vest and become exercisable in 12 equal quarterly installments thereafter on the first day of the applicable month beginning at the start of the first calendar quarter following July 27, 2022, subject to the reporting person's continued service relationship with the Issuer through each applicable vesting date.